Abstract: Epidemiologic studies support the premise that Allium vegetables may lower the risk of cancers. The benefi cial effects appear related to the organosulfur products generated upon processing of Allium. Leukemia cells from patients with acute myeloid leukemia (AML) display high proliferative capacity and have a reduced capacity of undergoing apoptosis and maturation. Whether the sulfur-containing molecules thiosulfi nates (TS), diallyl TS (All 2 TS), dipropyl TS (Pr 2 TS) and dimethyl TS (Me 2 TS), are able to exert chemopreventative activity against AML is presently unknown. The present study was an evaluation of proliferation, cytotoxicity, differentiation and secretion of AML cell lines (U937, NB4, HL-60, MonoMac-6) in response to treatment with these TS and their related sulfi des (diallylsulfi de, diallyl disulfi de, dipropyl disulfi de, dimethyl disulfi de). As assessed by fl ow cytometry, ELISA, gelatin zymogaphy and RT-PCR, we showed that Pr 2 TS and Me 2 TS, but not All 2 TS and sulfi des, 1) inhibited cell proliferation in dose-and time-dependent manner and this process was neither due to cytotoxicity nor apoptosis, 2) induced macrophage maturation, and 3) inhibited the levels of secreted MMP-9 (protein and activity) and TNF-α protein, without altering mRNA levels. By establishing for the fi rst time that Pr 2 TS and Me 2 TS affect proliferation, differentiation and secretion of leukemic cell lines, this study provides the opportunity to explore the potential effi ciency of these molecules in AML.
Introduction
Acute myeloid leukemia (AML) is a deadly disease, resulting from the clonal expansion and accumulation of hematopoietic stem cells arrested at various stages of development (Mason et al 2006; Plesa et al 2008) . Leukemia cells are unable to undergo growth arrest, terminal differentiation and apoptosis in response to appropriate environmental stimuli, and prematurely egress from the bone marrow to disseminate into peripheral tissues (Mason et al 2006; Plesa et al 2008) . The standard approach to AML remains chemotherapy, and the novel agents currently available (multidrug resistance inhibitors, farnesyltransferase inhibitors, receptor kinase inhibitors, monoclonal CD33 antibody-mediated drugs) (King et al 2007; Thomas et al 2007) show some effi cacy in either monotherapy or in combination with conventional chemotherapeutic drugs such as anthracycline, cytarabine or idarubicin (Adachi et al 2004; Leone et al 2006; Thomas et al 2007) . The development of new compounds directed against leukemia-specifi c targets is however needed to increase the cure rate in AML patients exhibiting chemoresistance and poor outcomes.
Allium vegetables (including garlic, onions, leeks, chives, and scallions) are used throughout the world for their sensory characteristics as well as their apparent health benefi ts (Amagase 2006; Borek 2006; Milner 2006) . They exhibit antimicrobial, antithrombotic, antitumor, antiarthritic and hypoglycemic properties (Ackermann et al 2001; Pinto et al 2001; Khanum et al 2004; Amagase 2006; Borek 2006; Milner 2006) which are largely attributed to the presence of sulfur compounds in these plants ( Le Bon et al 2000; Lanzotti 2006) . For example, the major sulfur-containing molecules in intact garlic are sulfoxides, which are converted into thiosulfi nates (such as Allicin) when raw garlic is cut or crushed (Amagase 2006; Lanzotti 2006) . Allicin (diallyl thiosulfi nate/All 2 TS) ( Figure  1 ) is rapidly decomposed to diallyldisulfi de (DADS) (Figure  1 ), diallylsulfi de (DAS) (Figure 1 ), diallyltrisulfi de (DATS) (Figure 1 ) and sulfur dioxide, and therefore does not seem to be a genuine active compound of garlic (Amagase 2006) . DADS and DATS exert antiproliferative and proapoptotic effects in human epithelial cancer and neuronal cell lines (Sundaram et al 1996b; Pinto et al 2001; Hosono et al 2005; Milner 2006; Xiao et al 2005 Xiao et al , 2006 . DADS induces apoptosis in the leukemic HL-60 cell line through activation of caspase-3 (Kwon et al 2002) , and inhibits NO synthesis in LPS-activated macrophages (Ippoushi et al 2002) . DATS also stimulates apoptosis of HL-60 cells (Zheng et al 1997) and inhibits platelet function by inhibiting platelet aggregation and Ca(2+) mobilization (Qi et al 2000) .
Other thiosulfi nates such as dipropyl thiosulfi nate (Pr 2 TS) and dimethyl thiosulfi nate (Me 2 TS) ( Figure 1 ) are mainly identifi ed in onion and leek (Lanzotti 2006) . Pr 2 TS, Me 2 TS and All 2 TS are found to inhibit platelet aggregation through inhibition of calpain (Rendu et al 2001) , by reaction with surface free sulfhydryls and internal thiol-containing proteins (Badol et al 2007) .
Whether Pr 2 TS, Me 2 TS and All 2 TS are able to exert chemopreventative activity against AML is presently unknown. With the above in mind, we undertook this study to evaluate the in vitro effi cacy of these compounds on human cell lines representative of AML. We show that Pr 2 TS and Me 2 Ts, but not All 2 TS and their related sulfi des, inhibit the growth of AML cell lines and interfere with the secretion of tumor necrosis factor-α (TNF-α) and matrix metalloproteinase-9 (MMP-9). Additional studies are warranted to investigate the inhibitory activity of Pr 2 TS and Me 2 TS in AML patients' cells ex vivo.
Materials and methods

Chemicals and antibodies
Monoclonal antibodies (mAbs) (fl uorescein isothiocyanate, FITC; phycoerythrin, PE) specific for CD11b (mIgG1, BEAR1), CD13 (mIgG1, SJ1D1), CD15 (mIgM, 80H5), CD44 (mIgG1, J-173), Apo 2.7 (mIgG1, 27AGA3), their isotypes and the Annexin V-FITC staining kit were obtained from Coulter/Beckman (Luminy, France). Irrelevant mouse (m)IgGs (FITC and PE) were obtained from R&D (Adbington, UK). Phorbol myristate acetate (PMA), nigericin, dimethyl disulfi de (DMDS), dipropyl disulfi de (DPDS), diallylsulfi de (DAS), and diallyl disulfi de (DADS) were obtained from Sigma-Aldrich (Saint Louis, MO, USA). Diallyl thiosulfi nate (All 2 TS), dipropyl thiosulfi nate (Pr 2 TS) and dimethyl thiosulfi nate (Me 2 TS) were synthesized as previously described (Auger et al 1990) . Organosulfurcompounds were solubilized in water. The stability of TS was assessed by HPLC analysis (Arnault et al 2003) . Alltrans retinoic acid was provided by Ares-Serono (Geneva, Switzerland).
Human AML cell lines and cell culture
Models of AML were represented by U937 cell line (monoblastic stage, AML-M5) (Ferrara et al 2001) (American Tissue Cell Culture), HL-60 cell line (promyelocytic stage, AML-M2) (Drexler et al 1999) supplemented with 5% heat-inactivated fetal calf serum (FCS; Gibco, Paisley, Scotland, LPS levels Ͻ0.1 ng/mL), 2 mM L-glutamine, 1 mM sodium pyruvate and 40 μg/ml gentamycin (Flow laboratories, Rockwell, MD) in a 5% CO 2 humidifi ed atmosphere at 37 °C. Cells (1-2 × 10 5 /mL) were cultured in complete RPMI 1640 medium at 37 °C in the absence or presence of various concentrations of compounds (10 −7 -10 −4 M). After various periods of incubation, cells were collected, washed twice, and living cells (with diameters ranging from 7 to 14 μm) were counted in a cell Coulter Counter ZM equipped with a Coultronic 256 channelizer (Coulter/Beckman). Maturation of cells toward the monocyte/macrophage or granulocytic pathway was determined according to the change in morphology assessed by staining cytocentrifuged cells (using a Shandon 3 Cytospin, Thermo Electron) with the Hemacolor kit from Merck and light microscope examination, and quantifi cation of several phenotypic markers characteristic of cell maturation into macrophages (CD11b) or granulocytes (CD15, CD13, CD44) as assessed by fl ow cytometry analysis (see below).
Flow cytometry analysis of cell differentiation, apoptosis and death
Intact cells were immunostained with Abs directed against CD11b, CD13, CD15, CD44 as described (Bauvois et al 2002) . Analysis was performed in a FACS fl ow cytometer analyzer (Coulter-Beckman, Luminy, France). Values are given as percentages of positive cells and antigen relative density per cell (obtained by subtracting the peak channel number of the negative control from the peak channel number of the corresponding experimental sample). Apoptosis was determined by the binding of Annexin-V-FITC to phosphatidylserine exposed to the cell membrane, used in conjunction with propidium iodide (PI), to evaluate subpopulations of cells along the apoptotic pathway according to the manufacturer's instructions.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA extraction from treated cells and cDNA synthesis were conducted as described (Bauvois et al 2002) . Specifi c human primers for human β2-microglobulin, MMP9, TNF-α, and vascular endothelial growth factor (VEGF), chosen according to published sequences (Westphal et al 2000; Bauvois et al 2002; Stordeur et al 2002; Parks et al 2004) were as follows: β2-microglobulin (165 bp), 5'-CAT CCA GCG TAC TCC AAA GA-3' (forward) and 5'-GAC AAGT CTG AAT GCT CCA C-3' (reverse); MMP-9 (296 bp), 5'-GGA GAC CTG AGA ACC AAT CTC-3' (forward) and 5'-TCC AAT AGG TGA TGT TGT CGT-3' (reverse); VEGF (204 bp), 5'-ACA TCT TCC AGG AGT ACC CTG ATG AG-3' (forward) and 5'-GCA TTC ACA TTT GTT GTG CTG T-3' (reverse); TNF-α (406 bp), 5'-ACC ATG AGC ACT GAA AGC AT-3' (forward) and 5'-AGA TGA GGT ACA GGC CCT CT-3' (reverse). The PCR products were visualized by electrophoresis in 2% agarose gel containing 0.2 μg/ml ethidium bromide. The β2-microglobulin gene was used to normalize the PCR products. The NIH Image 1.63 software was used for the analysis of the bands after acquisition in an Appligen densitometer (Oncor).
Measurement of MMP-9 gelatinolytic activity by zymography
Analysis of MMP-9 activity was carried out in 7.5% (w/v) SDS-polyacrylamide gels containing 0.2% gelatin (w/v) as described elsewhere (Bauvois et al 2002) . Equal amounts of culture media (20 μl) were applied to the gel in Laemmli sample buffer lacking β-mercaptoethanol. Gelatinolytic activities of pro-MMP-9 (92 kDa) and mature MMP-9 (82 kDa) were detected as transparent bands on the background of Eza-blue stained gelatin. The bands were acquired with an Appligen densitometer (Oncor).
Enzyme-linked immunosorbent assays
The culture supernatant fractions from cells (10 5 cells/mL) cultured for 3 days in the absence or presence of thiosulfi nates were harvested under sterile conditions and frozen before MMP-9, VEGF, and TNF-α contents were determined using commercial ELISA kits provided by R&D (Abingdon, UK). Controls included FCS-supplemented RPMI 1640 medium alone incubated under the same conditions. The concentrations were calculated after substraction of the control values. Detection level was 10 pg/mL for TNF-α and VEGF, and 1 ng/mL for MMP-9.
Statistical analysis
Values are represented as means ± SD of n independent experiments.
Results
Pr2TS and Me2TS induce growth arrest of AML cell lines
The antiproliferative potential of All 2 TS, Pr 2 TS and Me 2 TS and their related sulfi des (DADS, DAS, DMDS, DPDS) were fi rst evaluated in the U937 cell line. Cells were cultured 3 days in the absence or in the presence of increasing concentrations of the compounds (10 Figure 2B ) with IC 50 values (half-maximal inhibitory concentrations) of 2 μM, whereas their related sulfi des in the same range of concentration did not alter cell growth ( Figure 2C ). All 2 TS, DAS, and DADS did not affect cell growth ( Figure 2D ) and HPLC analysis showed that All 2 TS was totally degraded upon 24 h cell culture. Kinetic studies indicated also a timedependent inhibitory effect of Pr 2 TS and Me 2 TS on cell growth ( Figure 3A ). NB4 and MonoMac-6 cell lines were also sensitive to Pr 2 TS and Me 2 TS ( Figure 3B ).
Pr2TS and Me2TS do not induce U937 cell death
We next questioned whether the inhibition of U937 cell growth by Pr 2 TS and Me 2 TS was associated with cytotoxicity. The criteria for cell death, measured by Cell Coulter analysis, was based on the number of necrotic cells with diameters Յ7 μm (refl ecting cell shrinkage), and Figure 2A and B shows that Pr 2 TS and Me 2 TS tested did not induce a marked cytotoxic effect. It was next investigated whether decreased growth was related to apoptosis. To this end, we analyzed the surface binding of Annexin V, known as an early marker of apoptosis (Martin et al 1995) with simultaneous PI staining for necrotic cells. Figure 4 shows a representative experiment in which U937 cells were cultured for 3 days in the absence or presence of Pr 2 TS, Me 2 TS (5 μM) in comparison to the proapoptotic agent nigericin as a positive control. In contrast to untreated U937 cells ( Figure 4A ), cells treated with nigericin were strongly positive for Annexin V (L4 = 34%, Figure 4B , apoptotic cells) and for both Annexin V and PI (L2 = 40%, Figure 4B , secondary necrotic cells). U937 cells treated with Pr 2 TS or Me 2 TS were found weakly positive for Annexin V (L4 Յ 14%), and for both Annexin V and PI (L2 Յ 11%, Figure 4B and 4C). Moreover, using Apo 2.7 antibody which reacts with a mitochondrial protein exposed on cells undergoing apoptosis, we confi rmed that Pr 2 TS and Me 2 TS did not induce U937 cell apoptosis (data not shown).
Pr2TS and Me2TS induce differentiation of AML cells towards macrophages
The capacity of U937 cells to undergo macrophage maturation was further measured by examining the (Kim et al 1991) . At day 4, the block in growth of Pr 2 TS-and Me 2 TS-treated U937 cells was correlated with a marked enhanced expression of CD11b as compared to untreated cells ( Figure 5A ). In parallel, a change in morphology (increase in cell size, decrease in the nuclear/cytoplasmic ratio and apparition of vacuolisation) consistent with macrophage differentiation was observed in cells exposed to Pr 2 TS and Me 2 TS when compared to untreated cells ( Figure 5B ). As positive control, PMA-treated cells presented morphological features of cell maturation and these modifi cations were accompanied by the up-regulation of CD11b ( Figure 5A and B 
Inhibitory effects of Pr2TS and Me2TS on MMP-9 and TNF-α release by U937 and NB4 cells
As assessed by ELISA and zymography analyses of the conditioned media from day 3-cultured cells, very low amounts of matrix metalloproteinase-9 (MMP-9, 92 kDa) were produced by U937 cells and NB4 cells (Ͻ10 ng/mL). In parallel, no change in MMP-9 mRNA expression was observed to Pr 2 TS or Me 2 TS (from 24 to 72 h, data not shown). As described previously (Watanabe et al 1993) , exposure to PMA markedly increased the levels of released MMP-9 as assessed by its gelatinolytic activity (about 10-fold increase, Figure 6A ). Addition of Pr 2 TS or Me 2 TS (5 μM) to the culture medium resulted in a reduction of released MMP-9 activity from PMA-activated cells ( Figure 6A ). ELISA data ). Data represent the means of 2 to 6 independent determinations ± SD. (B) U937, NB4 and MonoMac-6 cells (10 5 /mL) were cultured in the absence or presence of 5 μM Pr 2 TS or Me 2 TS for 3 days (U937, NB4, MonoMac-6). Results are expressed as percentage of untreated cells. (100% = 9 × 10 5 cells/mL ± 10 5 for U937 and MonoMac-6; 100% = 8 × 10 5 cells/mL ± 10 5 for NB4). Data represent the means of n independent determinations ± SD (n = 7 to 13 for U937; n = 5 to 6 for MonoMac-6; n = 3 to 6 for NB4). Antiproliferative effects of thiosulfi nates confi rmed that diminished MMP-9 gelatinolytic activity resulted from the decrease in MMP-9 protein ( Figure 6B ). PCR analysis was used to examine the steady-state MMP-9 mRNA alteration before and after Pr 2 TS or Me 2 TS treatment. As shown in Figure 6C , Pr 2 TS or Me 2 TS did not alter the apparent levels of MMP-9 transcripts in PMA-activated cells treated for 24 h. In parallel, the amounts of TNF-α protein released from PMA-activated cells were also strongly diminished following Pr 2 TS or Me 2 TS treatment ( Figure 7A ) while the mRNA contents of TNF-α were slightly affected by Pr 2 TS or Me 2 TS at 24 h ( Figure 7B ), TNF-α mRNA/β2 mRNA ratios being decreased by 25% for Pr 2 TS and 49% for Me 2 TS. In both cell types, vascular endothelial growth factor (VEGF) protein and mRNA levels remained almost unchanged by Pr 2 TS and Me 2 TS ( Figure 7A and B).
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Discussion
Our present study provides new information about the infl uence of thiosulfi nates (TS) in human malignant myeloid cell lines which are representative of acute myeloid leukemia cells accordingly to the French-American-British (FAB) classifi cation. These are HL-60 (FAB M2), NB4 (FAB M3), U937 and MonoMac-6 (FAB M5) cell lines.
We fi rst describe the ability of Pr 2 TS and Me 2 TS to inhibit in a concentration-and time-dependent manner the growth of leukemic cells in vitro. The comparison with their sulfi de analogues (DPDS and DMDS) which do not show any infl uence on cell proliferation in the same range of concentration (up to 100 μM), suggests that the sulfoxide group plays a critical role in TS activity. In contrast, All 2 TS as well as its sulfi de analogues DAS and DADS did not affect cell growth, and such lack of effect of All 2 TS was associated to its decomposition to sulfi des as previously reported (Amagase 2006) . In contrast to our study, allyl sulfi des (from 10 to 100 μM) have been reported to reduce in culture and in vivo the growth rate of human cancer cell lines derived from solid tumors (Sundaram et al 1996b; Hosono et al 2005; Xiao et al 2005 Xiao et al , 2006 Milner 2006) , possibly by regulating factors involved in cellular proliferation such as NF-κB (Pinto et al 2001) or p21 (Milner 2006) . Further research is required to clarify the mechanisms of inhibition of AML cell proliferation by Pr 2 TS and Me 2 TS. The mitogen-activated protein kinase (MAPK) pathway that proceeds from Ras, and its downstream effector Raf to MAPK kinase (MEK) and extracellular signal activated kinase (ERK), links various extracellular stimuli to proliferation, differentiation and survival. The MAPK signaling is constitutively active in blast cells of the majority of AML patients, and its blockade by selective small molecules inhibitors impairs leukemic cell proliferation (Milella et al 2001; Platanias 2003) . It has also to be pointed out that the level of NF-κB is high in AML (Baumgartner et al 2002) . Whether Pr 2 TS and Me 2 TS block NF-κB or MAPK activities is currently under investigation.
Organosulfur compounds may exhibit proapoptotic actions on various models of human cancers (Sundaram et al 1996a; Kwon et al 2002; Xiao et al 2003 Xiao et al , 2005 Herman-Antosiewicz et al 2004; Hosono et al 2005) . However, our experiments clearly indicate that Pr 2 TS and Me 2 TS do not induce cell apoptosis. Instead, the block in AML cell growth by Pr 2 TS and Me 2 TS is accompanied by differentiation of cells toward the monocyte/macrophage pathway as assessed by phenotypic and morphologic features. TNF-α is an autocrine stimulus for supporting macrophage differentiation (De Benedetti et al 1990; Kamijo et al 1990) . By ELISA analysis, we showed that unstimulated cells secreted very low levels of TNF-α (2 ± 0.17 pg/mL/10 5 cells) which were not altered with Pr 2 TS (1.81 ± 0.17 pg/mL/10 5 cells) (168) 42 (28) 47 (169) 48 (197) 2) on NB4 CD15 ↑ 55 (17) 82 (98) 58 (26) 39 (16) Notes: Cells cultured for 5 days in the absence (control) or presence of ATRA (10 μM), Pr 2 TS or Me 2 TS (5 μM) were assayed for expression of surface CD13, CD15 and CD44. Values are given as % of CD positive cells and CD relative density per cell (in brackets), up-regulation of CD15 (Lanotte et al 1991; Trayner et al 1998; Barber et al 2008) ; down-regulation of CD13 and CD44 (Trayner et al 1998; Barber et al 2008) . Antiproliferative effects of thiosulfi nates or Me 2 TS (1.94 ± 0.19 pg/mL/10 5 cells ) thus indicating that endogenous TNF-α is not implicated in Pr 2 TS-/ Me 2 TS-mediated cell maturation. The molecular mechanisms involved in regulating the balance between proliferation and differentiation in the monocytic/macrophage lineage remain poorly understood. The retinoblastoma gene product (Bergh et al 1999) , interferon regulatory factors (Manzella et al 1999; Lu et al 2001) and the Ets repressor PE-1/METS (Sawka-Verhelle et al 2004) have been reported to play a critical role in the monocytic commitment. Whether Pr 2 TS and Me 2 TS could infl uence the activity of these factors remains to be determined. Differentiation therapy with retinoic acid plays an important role in treating acute promyelocytic leukemia (Jurcic et al 2007) . Our data suggests that the addition of specifi c agents such as Pr 2 TS or Me 2 TS to differentiation therapy could be explored.
AML is an hematological disorder which is associated with an increased angiogenesis which disappears if complete hematological remission is achieved (Rajkumar et al 2002; Ribatti et al 2004; Longo et al 2007) . Because of its capacities to degrade components of the extracellular matrix and angiogenic factors, MMP-9 can play a role in cancer progression by affecting tumor angiogenesis, tumor growth and/or metastasis (Opdenakker et al 2003; Parks et al 2004; Deryugina et al 2006) . MMP-9 is synthesized as a preproenzyme, secreted as a proform (92 kDa) and processed in a 82 kDa form resulting from the proteolytic removal of a fragment of its N-terminal domain (Opdenakker et al 2003) . AML leukemic cells express and release 92 kDa MMP-9 (Klein et al 2004) . We show here that Pr 2 TS and Me 2 TS decrease MMP-9 production by activated U937 and NB4 cells. At the mRNA level, no early regulation was detectable indicating a post-transcriptional event. In connection with organosulfurs, Meyer and colleagues (2004) showed that DADS inhibit the secretion of MMP-9 by HUVEC cells while not affecting MMP-9 mRNA levels. Besides MMP-9, VEGF and TNF-α are important partners of angiogenesis (Kini et al 2001; Thomas et al 2001; Ribatti et al 2004) . In addition to its angiogenic properties, VEGF may serve as an autocrine/paracrine growth factor for leukemia cells (Fiedler et al 1997; Rajkumar et al 2002) . TNF-α stimulates various NF-κB target genes that modulate cell survival and proliferation, tumor metastasis and angiogenesis (Braun et al 2006; Cilloni et al 2007) . Among NF-κB target genes are MMP-9 and Bcl-2 whose proteins levels are enhanced in AML (Mayo et al 2000; Braun et al 2006) . A previous study showed that DADS inhibited the production of IL-1β and TNF-α by blood monocytes stimulated with lipopolysaccharide (Keiss et al 2003) . Our results indicate that Pr 2 TS and Me 2 TS inhibit TNF-α production by U937 and NB4 cells at the post-transcriptional level, without affecting VEGF expression. Whether Pr 2 TS and Me 2 TS inhibit the synthesis or the release of MMP-9 and TNF-α remains to be determined.
In conclusion, this work provides fi rst evidence that Pr 2 TS and Me 2 TS may exhibit antitumor activity against AML cell lines by affecting cell growth, differentiation and secretion of factors involved in tumoral processes. Our data suggest that these TS are promising compounds for improving AML therapy. A very recent study has demonstrated selective apoptosis of childhood pre-B acute lymphoblastic leukemia cells in vitro by DATS and ajoene (Hodge et al 2008) emphasizing the potential of Allium for possible treatment of human leukemias. Further studies are required to validate our observations with these TS in AML patients' cells.
